Future Innovation Group, Inc. (TYO:4392)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,107	8,562	9,535	11,488	9,509	7,817
Market Cap Growth	-20.89%	-10.20%	-17.00%	20.82%	21.65%	-9.02%
Enterprise Value	11,593	10,721	17,423	17,912	15,567	10,820
Last Close Price	301.00	283.00	305.40	372.19	301.51	245.04
PE Ratio	-	-	45.41	16.77	21.56	46.25
PS Ratio	0.73	0.71	0.71	0.89	0.78	0.76
PB Ratio	1.12	1.05	0.99	1.18	1.07	0.94
P/TBV Ratio	1.25	1.16	1.08	1.29	1.19	1.05
P/FCF Ratio	-	3.04	-	-	-	-
P/OCF Ratio	-	2.71	-	32.00	150.93	18.97
EV/Sales Ratio	0.93	0.89	1.29	1.39	1.27	1.05
EV/EBITDA Ratio	-	12.06	14.53	12.96	15.34	53.30
EV/EBIT Ratio	25.82	29.37	24.07	19.20	27.50	-
EV/FCF Ratio	-	3.81	-	-	-	-
Debt / Equity Ratio	0.54	0.58	1.07	0.88	0.83	0.57
Debt / EBITDA Ratio	-	5.36	8.58	6.19	7.29	23.21
Debt / FCF Ratio	-	1.69	-	-	-	-
Asset Turnover	0.73	0.62	0.61	0.64	0.72	0.73
Inventory Turnover	3.97	3.53	4.23	4.35	4.61	4.44
Quick Ratio	1.55	1.56	1.85	1.94	1.06	1.36
Current Ratio	2.10	2.11	2.29	2.42	1.39	1.79
Return on Equity (ROE)	-17.29%	-16.05%	2.21%	7.29%	5.11%	2.04%
Return on Assets (ROA)	1.65%	1.18%	2.04%	2.88%	2.07%	-1.25%
Return on Capital (ROIC)	1.98%	1.39%	2.37%	3.38%	2.42%	-1.49%
Return on Capital Employed (ROCE)	4.30%	3.40%	4.50%	6.00%	4.80%	-
Earnings Yield	-16.86%	-16.49%	2.20%	5.96%	4.64%	2.16%
FCF Yield	-	32.89%	-9.86%	-6.91%	-22.23%	-12.42%
Dividend Yield	1.67%	1.77%	1.64%	1.34%	1.66%	2.04%
Payout Ratio	-	-	143.33%	21.31%	32.88%	84.61%
Buyback Yield / Dilution	1.04%	1.04%	-2.60%	-0.36%	-1.02%	-3.29%
Total Shareholder Return	2.72%	2.80%	-0.97%	0.98%	0.64%	-1.25%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.